The incidence of bladder cancer continues to increase, with an estimat
ed 53,000 new cases diagnosed in the United States in 1996-90% of whic
h are transitional cell carcinomas. The male-to-female ratio is 3:1.A
number of etiological factors are associated with the development of b
ladder cancer, but in industrialized countries, cigarette smoking is t
he most important. Specific chemicals have also been identified as cau
sing bladder cancer, as have a number of occupational exposures to les
s well-defined specific agents. Treatment with cytostatic drugs, espec
ially cyclophosphamide, is associated with increased risk of bladder c
ancer, as is treatment with radiotherapy for uterine cancer. In develo
ping countries, especially in the Middle East and parts of Africa, inf
ections with members of the genus Schistosoma are responsible for a hi
gh incidence of bladder cancer-75% of which ale squamous cell carcinom
as. Arsenic has been indicated as a bladder carcinogen in Argentina, C
hile, and Taiwan. The reason for the high incidence of urinary tract c
ancer in individuals suffering from Balkan nephropathy has yet to be d
etermined. A careful history of patients with bladder cancer is an imp
ortant and useful process in helping to identify causal factor and, in
more than one-half the cases, a known relationship is found. Bladder
cancer is a potentially preventable disease, with a significant morbid
ity and mortality in many parts of the world. (C) 1997 Wiley-Liss, Inc
.